You have 9 free searches left this month | for more free features.

DOAC

Showing 51 - 75 of 167

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Elaboration ofPrioritization Score for Pharmaceutical Interviews

Completed
  • Thromboembolic Event
  • Survey
  • Reims, France
    Chu Reims
Oct 19, 2023

Radial Artery Occlusion Trial in Kingston, Ottawa (Rivaroxaban 15 MG Oral Tablet [Xarelto])

Recruiting
  • Radial Artery Occlusion
  • Rivaroxaban 15 MG Oral Tablet [Xarelto]
  • Kingston, Ontario, Canada
  • +1 more
Feb 8, 2022

Polypharmacy, Insomnia, Anticoagulants Trial in Ann Arbor (Academic Detailing (AD), LEAP)

Recruiting
  • Polypharmacy
  • +2 more
  • Academic Detailing (AD)
  • LEAP
  • Ann Arbor, Michigan
    VA Ann Arbor Healthcare System, Ann Arbor, MI
Jul 18, 2022

Coagulation Disorder Trial in Groningen (VMX-C001, Placebo, Apixaban)

Recruiting
  • Coagulation Disorder
  • Groningen, Netherlands
    QPS Netherlands B.V.
Dec 7, 2021

Medicines That Help in Thinning Blood in People With Atrial

Not yet recruiting
  • Atrial Fibrillation
  • No OAC
  • +4 more
  • (no location specified)
Apr 28, 2023

Hip Fractures Trial in Calgary (Rivaroxaban 10mg, acetylsalicylic acid (ASA) 81mg Oral Tablet)

Not yet recruiting
  • Hip Fractures
  • Rivaroxaban 10mg
  • acetylsalicylic acid (ASA) 81mg Oral Tablet
  • Calgary, Alberta, Canada
    Foothills Medical Centre
Mar 7, 2023

Subdural Hematoma, Atrial Fibrillation Trial in Toronto (Direct Acting Oral Anticoagulant starting at Day 30, Direct Acting Oral

Not yet recruiting
  • Subdural Hematoma
  • Atrial Fibrillation
  • Direct Acting Oral Anticoagulant starting at Day 30
  • Direct Acting Oral Anticoagulant starting at Day 90
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
Jul 26, 2022

Concentration of Direct Oral Anticoagulants in Atrial

Not yet recruiting
  • Oral Anticoagulant
  • +2 more
    • (no location specified)
    Dec 23, 2020

    Healthy Volunteer Trial in Leeds (Aspirin, rivaroxaban low dose, rivaroxaban high dose)

    Recruiting
    • Healthy Volunteer
    • Leeds, West Yorkshire, United Kingdom
      LabCorp CRU
    Jan 24, 2023

    COVID-19 Trial in London (Aspirin 75mg, Clopidogrel 75mg, Rivaroxaban 2.5 MG)

    Terminated
    • COVID-19
    • Aspirin 75mg
    • +4 more
    • London, United Kingdom
      Charing Cross Hospital
    Jan 13, 2023

    Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments

    Completed
    • Hemophilia A
    • +2 more
    • Vitamin K Antagonist - Drug
    • Brest, France
    • +5 more
    Apr 6, 2023

    Venous Thrombosis, Tumors, Anticoagulant Trial in Kyoto (12-month Edoxaban, 3-month Edoxaban)

    Active, not recruiting
    • Venous Thrombosis
    • +2 more
    • 12-month Edoxaban
    • 3-month Edoxaban
    • Kyoto, Japan
      Department of Cardiovascular Medicine, Kyoto University Graduate
    Aug 16, 2022

    Oral Anticoagulants in Italian Elderly Non-Valvular Atrial

    Recruiting
    • Non-Valvular Atrial Fibrillation (NVAF)
      • Milano, MI, Italy
        Ecol Studio SpA
      Jan 31, 2022

      Adherence, Medication, Statin Adverse Reaction, Anticoagulant Adverse Reaction Trial (Questionnaires to report barriers to

      Recruiting
      • Adherence, Medication
      • +2 more
      • Questionnaires to report barriers to medication adherence
      • Leeds, West Yorkshire, United Kingdom
        Leeds Teaching Hospitals Trust
      Aug 24, 2022

      Knowledge, Attitudes, Practice Trial (Anticoagulation Educational Materials, Control Group: Standard of Care)

      Not yet recruiting
      • Knowledge, Attitudes, Practice
      • Anticoagulation Educational Materials
      • Control Group: Standard of Care
      • (no location specified)
      Nov 17, 2023

      Atrial Fibrillation Trial in Ottawa (Apixaban, Rivaroxaban)

      Recruiting
      • Atrial Fibrillation
      • Ottawa, Ontario, Canada
        The Ottawa Hospital - General Campus
      Mar 14, 2022

      Esophageal Cancer, Gastric Cancer Trial in Worldwide (Surveillance protocol)

      Not yet recruiting
      • Esophageal Cancer
      • Gastric Cancer
      • Surveillance protocol
      • Cologne, Germany
      • +12 more
      Oct 29, 2023

      Direct Oral Anticoagulants for the Treatment of Mural Thrombus

      Completed
      • Acute Myocardial Infarction
        • Dallas, Texas
          Methodist Dallas Medical Center
        Dec 9, 2021

        Direct Oral Anticoagulants (DOACs) in Hypercoagulable States

        Completed
        • Hypercoagulable States
        • Observational
        • Dallas, Texas
          Methodist Dallas Medical Center
        Dec 9, 2021

        Hemorrhage, Surgical, Hemorrhage Postoperative, Blood Loss, Surgical Trial in United States (Sham comparator, DrugSorb-ATR

        Recruiting
        • Hemorrhage, Surgical
        • +3 more
        • Sham comparator
        • DrugSorb-ATR system
        • Sacramento, California
        • +23 more
        Jul 20, 2022

        Pancreas Cancer, DVT, Pulmonary Embolism Trial in Philadelphia (Apixaban)

        Completed
        • Pancreas Cancer
        • +2 more
        • Philadelphia, Pennsylvania
          Thomas Jefferson University Clinical Research Unit
        Dec 6, 2021

        Myocardial Infarction, Acute, Left Ventricular Thrombus Trial in Paris (Rivaroxaban 2.5 MG [Xarelto], DAPT strategy)

        Recruiting
        • Myocardial Infarction, Acute
        • Left Ventricular Thrombus
        • Rivaroxaban 2.5 MG [Xarelto]
        • DAPT strategy
        • Paris, France
          HEGP
        Oct 22, 2021

        Anticoagulants; Increased Trial (catheter induced thromboprophylaxis)

        Not yet recruiting
        • Anticoagulants; Increased
        • catheter induced thromboprophylaxis
        • (no location specified)
        Jan 21, 2023

        CTEPH Trial in Fukuoka (Edoxaban, Warfarin Potassium, Warfarin Potassium )

        Active, not recruiting
        • CTEPH
        • Fukuoka, Japan
          Kyushu University Hospital
        Aug 30, 2022

        Venous Thromboembolism Trial in Canada (Apixaban, Rivaroxaban)

        Recruiting
        • Venous Thromboembolism
        • Calgary, Alberta, Canada
        • +16 more
        Mar 14, 2022